Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.

Marc PuigvehíMaría-Carlota LondoñoXavier TorrasSara LorenteMercedes VergaraRosa Maria MorillasHelena MasnouTrinidad SerranoMireia MiquelAdolfo GallegoSabela LensJose Antonio Carrión

Published in: Journal of gastroenterology (2019)

HCV-cirrhotic patients can develop HR-GEV after SVR. Surveillance is especially recommended in those with GEV before antiviral treatment. Baveno and expanded-Baveno criteria can be safely applied after SVR. https://clinicaltrials.gov: NCT02758509.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
human immunodeficiency virus
patient reported
antiretroviral therapy